Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities. (December 2016) - Finetti, M.A.; Selby, M.P.; Del Carpio Pons, A.; Wong, J.P.; Bashton, M.; Cranston, R.E.; Barker, J.; Crosier, S.; Smith, A.; Ramli, R.A.; Grabovska, Y.; Bailey, S.; et al.